Controversy about pharmacological modulation of Nrf2 for cancer therapy

Cited by papers we hold 8

• An update of Nrf2 activators and inhibitors in cancer prevention/promotion · 2022
  No notice
• Anti-Angiogenic Therapy: Current Challenges and Future Perspectives · 2021
  No notice
• The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies · 2020
  No notice
• Regulation of Nrf2/ARE Pathway by Dietary Flavonoids: A Friend or Foe for Cancer Management? · 2020
  No notice
• The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/ARE Signaling Pathway in Chronic Diseases · 2019
  No notice
• Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development · 2019
  No notice
• Short Overview of ROS as Cell Function Regulators and Their Implications in Therapy Concepts · 2019
  No notice
• Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in Carcinogenesis · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.